spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare News Roundup: Biopharmaceutical

 HSMN NewsFeed - 22 Mar 2011
Synergy Pharmaceuticals Appoints Dr. Laura Barrow as Vice President of Clinical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Mar 2011
Data Presented at AAAAI Annual Meeting Further Support the Safety and Efficacy of FIRAZYR(R) (icatibant) for the Treatment of Acute Attacks of Hereditary Angioedema
Biopharmaceuticals
 HSMN NewsFeed - 22 Mar 2011
Mylan Announces Exclusive Distribution Partnership with Humeca to Expand Burn and Wound Care Portfolio
Biopharmaceuticals Licensing Distribution Wound Care
 HSMN NewsFeed - 22 Mar 2011
FDA Accepts for Review Spectrum Pharmaceuticals’ ZEVALIN(R) Submission for the Removal of the Bioscan
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 Mar 2011
TESARO Enters into Exclusive License Agreement with Amgen to Acquire Rights to Anaplastic Lymphoma Kinase (ALK) Program
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 21 Mar 2011
Phase III Study of Investigational Compound Ipilimumab Achieves Primary Endpoint of Improvement in Overall Survival in Previously-Untreated Patients with Metastatic Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Mar 2011
Cephalon Announces Definitive Agreement to Acquire Gemin X
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Mar 2011
Lithera Announces the Appointment of George W. Mahaffey as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Mar 2011
Regulus Therapeutics Appoints Lars Karlsson, M.D., Ph.D., VP of Immunology and Fibrosis
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Mar 2011
Genentech Announces Positive Pivotal Phase II Results for Hedgehog Pathway Inhibitor in Advanced Basal Cell Carcinoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Mar 2011
PharmStar Pharmaceuticals Appoints Howard Phykitt as Chairman and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Mar 2011
Amgen Statement on CHMP Opinion on Vectibix(R) (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 18 Mar 2011
Lilly and Avid Receive Complete Response Letter from FDA for Amyvid (florbetapir F 18 injection)
Biopharmaceuticals Radiology FDA
 HSMN NewsFeed - 17 Mar 2011
Elite Announces Settlement of Litigation With ThePharmaNetwork
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 17 Mar 2011
KaloBios Announces Two Significant Additions to Its Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Mar 2011
ARIAD Announces Election to Co-Promote Ridaforolimus in Sarcoma Indication in U.S. upon Approval
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 15 Mar 2011
Breakthrough Light-Activated Drug-Device to be Investigated for Treatment of HPV* and Cervical Pre-cancer
Biopharmaceuticals Devices Oncology
 HSMN NewsFeed - 15 Mar 2011
U.S. FDA Approves Bayer's Gadavist (Gadobutrol) Injection for MRI of the Central Nervous System
Biopharmaceuticals Radiology FDA
 HSMN NewsFeed - 15 Mar 2011
Incyte’s Ruxolitinib (INCB18424) Meets Primary Endpoint in Second Phase III Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Mar 2011
Omthera Pharmaceuticals Initiates Pivotal Phase III EVOLVE Trial for Epanova in Patients with Very High Triglycerides
Biopharmaceuticals
 HSMN NewsFeed - 14 Mar 2011
Omthera Pharmaceuticals Raises $33.9 Million in Series B Funding Led by New Enterprise Associates
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Mar 2011
Labopharm Announces Appointment of New President & CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Mar 2011
Cell Therapeutics Acquires Exclusive Marketing and Co-Development Rights in the Americas to Chroma Therapeutics' Tosedostat, a First in Class Tumor Selective Oral Therapy for Treatment of Blood Related and Other Cancers
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 11 Mar 2011
Tolerx and GlaxoSmithKline Announce Phase 3 Defend-1 Study of Otelixizumab in Type 1 Diabetes Did Not Meet Its Primary Endpoint
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 11 Mar 2011
Lantheus Medical Imaging Receives Special Protocol Assessment Approval from FDA for Phase 3 Trial of Flurpiridaz F-18 for the Diagnosis of Coronary Artery Disease
Biopharmaceuticals Radiology Cardiology FDA
 HSMN NewsFeed - 10 Mar 2011
Sanofi-aventis and Regeneron Report Top-line Results from Phase III Study with aflibercept (VEGF Trap) in Second-Line Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Mar 2011
Lilly Announces New Vice President of Oncology Research
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Mar 2011
Biothera Acquires MUC1 Anti-Cancer Monoclonal Antibody From Antisoma
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 9 Mar 2011
2011 Surgical Guidelines Recommend Point-of-Care Platelet Reactivity Testing Prior to Surgery
Diagnostics Biopharmaceuticals Surgery Cardiology
 HSMN NewsFeed - 9 Mar 2011
Pro-Pharmaceuticals Names Peter G. Traber, M.D., Former GlaxoSmithKline Chief Medical Officer & President Emeritus of Baylor College of Medicine, President & Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Mar 2011
Auxilium Pharmaceuticals, Inc. Completes Enrollment of XIAFLEX(R) Phase III Double-Blind Studies for Peyronie's Disease
Biopharmaceuticals
 HSMN NewsFeed - 8 Mar 2011
Stellar Biotechnologies Appoints Vice President, Business Development & Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Mar 2011
Vanda Pharmaceuticals Receives Orphan Drug Designation in Europe for tasimelteon
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 7 Mar 2011
Eisai Realigns Its U.S. Operations
Biopharmaceuticals
 HSMN NewsFeed - 7 Mar 2011
Rexahn Announces CEO Transition to CSO and Search for New CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Mar 2011
NeoStem Announces the Addition of Jason Kolbert as Vice President of Strategic Business Development
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 7 Mar 2011
Aerie Pharmaceuticals Completes $30 Million Series B Financing to Fund Further Development of Innovative Glaucoma Product Portfolio
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 3 Mar 2011
Targacept Announces Termination of Strategic Alliance Agreement with GlaxoSmithKline
Biopharmaceuticals
 HSMN NewsFeed - 3 Mar 2011
Gentium Appoints Adrian Haigh as Senior Vice President of Commercial Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Mar 2011
InterMune Receives European Union Approval for Esbriet(R) (pirfenidone)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 3 Mar 2011
EpiCept Identifies Ceplene(R) Survival Benefit in Key AML Subgroup
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Mar 2011
Celsion Receives European Orphan Drug Designation for ThermoDox(R) to Treat Primary Liver Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 2 Mar 2011
CorMedix Appoints Mark A. Klausner, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Mar 2011
GTx and Ipsen Terminate Their Toremifene Collaboration
Biopharmaceuticals
 HSMN NewsFeed - 1 Mar 2011
Paloma Pharmaceuticals Update on Ocular Clinical and Oncology Programs
Biopharmaceuticals Ophthalmology Oncology
 HSMN NewsFeed - 1 Mar 2011
BioSpecifics Technologies Corp. Announces Approval of XIAPEX(R) for Treatment of Dupuytren's Contracture in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 1 Mar 2011
Pfizer Completes Acquisition Of King Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 1 Mar 2011
NeuroPhage Pharmaceuticals Closes $12.4M Series B Round
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 1 Mar 2011
Forest Announces FDA Approval of Daliresp(TM) (Roflumilast) as a Treatment to Reduce the Risk of COPD Exacerbations in Patients with Severe COPD Associated with Chronic Bronchitis and a History of Exacerbations
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Feb 2011
FDA Approves INTUNIV(R) (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Feb 2011
Nile Therapeutics to Collaborate with Medtronic on Clinical Development of Cenderitide for Heart Failure and Renal Disease
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 28 Feb 2011
Nile Therapeutics Announces Plans to Pursue a Post-Acute Indication in Heart Failure
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 28 Feb 2011
Shire Files Complete Response to FDA's Not Approvable Letter for FIRAZYR(R) (icatibant) for the Treatment of Acute Attacks of Hereditary Angioedema
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Feb 2011
Arsanis, Inc Announces Series A Financing with OrbiMed Advisors, Polaris Venture Partners and SV Life Sciences
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Feb 2011
Santarus and Pharming Announce Receipt of FDA Refusal to File Letter for RHUCIN Biologics License Application
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Feb 2011
FDA Grants Full Approval for PROMACTA(R) (eltrombopag) for Treatment of Rare Blood Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Feb 2011
FDA Issues Complete Response Letter for Taliglucerase Alfa New Drug Application
Biopharmaceuticals
 HSMN NewsFeed - 24 Feb 2011
Pearl Therapeutics Appoints Charles (Chuck) Bramlage President and Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 24 Feb 2011
FDA Grants Genentech a Hearing on Avastin’s Use for Metastatic Breast Cancer in the United States
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Feb 2011
Omni Bio Pharmaceutical Realigns Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Feb 2011
Spectrum Pharmaceuticals Appoints Steven M. Fruchtman, MD, an Industry Veteran, as Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Feb 2011
Bayer and Onyx Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients With Advanced Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Feb 2011
Court of Appeals Overturns $1.8 Billion Patent Verdict for Centocor Ortho Biotech Inc.
Biopharmaceuticals Litigation
 HSMN NewsFeed - 23 Feb 2011
Thomas, McNerney & Partners Expands Team and Moves West Coast Office to San Diego
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 23 Feb 2011
Allon Appoints Dr. Michael Gold Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 23 Feb 2011
Genesis Biopharma Appoints L. Stephen Coles M.D., Ph.D. to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Feb 2011
Sunesis Receives FDA Fast Track Designation for Vosaroxin in AML
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Feb 2011
Sosei Receives Approval From Japan MHLW for NorLevo(R) TABLETS 0.75mg Emergency Contraceptive Pill
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Feb 2011
Masters Pharmaceutical, Inc. Appoints Wayne A. Corona to President and Chief Operating Officer
Biopharmaceuticals Distribution Personnel
 HSMN NewsFeed - 22 Feb 2011
Erica L. Mann, Former Pfizer Executive, Appointed New President of Bayer HealthCare's Global Consumer Care Division
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Feb 2011
Gilead Sciences to Acquire Calistoga Pharmaceuticals for $375 Million
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 22 Feb 2011
POZEN Announces Addition to Commercial Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Feb 2011
Jennerex Appoints James M. Burke, M.D. Vice President, Clinical Research
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Feb 2011
Delcath Systems Receives Refusal to File Letter From FDA
Devices Biopharmaceuticals Drug Delivery Oncology FDA
 HSMN NewsFeed - 22 Feb 2011
Santarus and Pharming Announce Initiation of Phase IIIb Clinical Study with RHUCIN in Acute Hereditary Angioedema
Biopharmaceuticals
 HSMN NewsFeed - 18 Feb 2011
Impax Laboratories Receives Final FDA Approval for Generic Adoxa(R) 150 mg Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 18 Feb 2011
MAP Pharmaceuticals Appoints Scott R. Ward as Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Feb 2011
AVANIR Pharmaceuticals Appoints Gregory J. Flesher to Senior Vice President and Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Feb 2011
Orexigen(R) Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Feb 2011
Stemedica Receives Approval From UCSD to Initiate Ischemic Stroke Study With Adult Allogeneic Stem Cells
Biopharmaceuticals Regenerative Medicine Neurology
 HSMN NewsFeed - 17 Feb 2011
Inspire Announces Corporate Restructuring and Strategic Focus on Eye Care Business
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 16 Feb 2011
Celgene Elects Michael A. Friedman, MD to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Feb 2011
Savient Pharmaceuticals Announces Executive Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Feb 2011
Versartis Completes $21 Million Series B Financing
Biopharmaceuticals Endocrinology Venture Capital
 HSMN NewsFeed - 16 Feb 2011
sanofi-aventis to Acquire Genzyme for $74.00 in Cash Per Share Plus Contingent Value Right
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Feb 2011
Halozyme Announces Roche Doses First Patient in Phase 3 Clinical Trial With Subcutaneous MabThera(R) (rituximab)
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Feb 2011
Aeolus Pharmaceuticals Announces Appointment of Russell L. Skibsted as Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Feb 2011
Aegerion Pharmaceuticals Appoints Diane L. Tribble, Ph.D., M.M.Sc., as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Feb 2011
Noven Appoints Lance D. Williams as Vice President of Human Resources
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Feb 2011
Optimer Pharmaceuticals Appoints Glenn Tillotson, Ph.D., to Senior Vice President of Medical Affairs and Announces Executive Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Feb 2011
BioSante Pharmaceuticals Reports Positive LibiGel(R) Safety Data in Phase III Program
Biopharmaceuticals
 HSMN NewsFeed - 14 Feb 2011
ADVENTRX Signs Definitive Agreement to Acquire SynthRx Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Feb 2011
Lucentis Phase III Study Meets Primary Endpoint for Improving Vision in Patients With Diabetic Macular Edema (DME)
Biopharmaceuticals Endocrinology Ophthalmology
 HSMN NewsFeed - 11 Feb 2011
Data Monitoring Committee Unanimously Recommends Continuation of Celsion's Phase III ThermoDox(R) HEAT Study to Treat Primary Liver Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Feb 2011
Lilly Announces Senior Leadership Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Feb 2011
Simcere Pharmaceutical Group Appoints Industry Veteran Mr. Hong Zhao as Executive Vice President of Sales and Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Feb 2011
Cytokinetics Announces Changes to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Feb 2011
3-V Biosciences Promotes Stephen R. Brady to Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Feb 2011
Covidien Receives FDA Approval for Fentanyl Transdermal System Patch
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 10 Feb 2011
Sanguine Announces Additions and Changes in Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Feb 2011
Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS
Biopharmaceuticals Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 9 Feb 2011
Geron Appoints David Greenwood President, Interim CEO and Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Feb 2011
Circassia Acquires Worldwide Rights to Novel Psoriasis and Atopic Dermatitis Treatment From Airmid Inc
Biopharmaceuticals Dermatology Acquisitions
 HSMN NewsFeed - 9 Feb 2011
Oncos Therapeutics Increases Clinical Momentum With Appointment of Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Feb 2011
Aqua Pharmaceuticals Welcomes Ted White as Vice President, Sales
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Feb 2011
Pervasis Receives FDA Fast Track Status for Vascugel(R) to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis
Biopharmaceuticals Interventional FDA
 HSMN NewsFeed - 8 Feb 2011
Osiris Therapeutics Strengthens Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Feb 2011
Third Phase III Study of Avastin-Based Regimen Met Primary Endpoint in Ovarian Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Feb 2011
FDA Approves Labeling Update for REYATAZ(R) (atazanavir sulfate) Capsules to Include Data Supporting the Recommended Adult Dose of REYATAZ/ritonavir 300/100 mg for HIV-1 Infected Pregnant Women
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 7 Feb 2011
Cellerant Therapeutics Announces Key Additions to Sr. Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Feb 2011
Aegerion Pharmaceuticals Appoints Martha J. Carter as Chief Regulatory Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Feb 2011
Alios BioPharma Names Carol L. Brosgart, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Feb 2011
Pfizer To Acquire Ferrosan’s Consumer Healthcare Business
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 4 Feb 2011
FDA Approves Makena, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm Birth
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Feb 2011
Zolpimist(TM) Oral Spray Launched in United States
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 4 Feb 2011
ECR Pharmaceuticals Launches Zolpimist Oral Spray
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 4 Feb 2011
Affymax Announces Appointment of Herb Cross as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Feb 2011
FDA Grants Orphan Drug Designation to Bayer's Investigational Compound Regorafenib for the Treatment of Gastrointestinal Stromal Tumors
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Feb 2011
Somaxon Pharmaceuticals Appoints Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Feb 2011
Cornerstone Therapeutics Appoints Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Feb 2011
Theratechnologies and Ferrer Announce a Distribution & Licensing Agreement for Tesamorelin in Europe
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 3 Feb 2011
Noxxon Expands Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Feb 2011
Otonomy Adds Key Product and Industry Experience with Appointment of New Vice Presidents
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Feb 2011
Valeant Pharmaceuticals to Acquire U.S. and Canadian Rights to Zovirax(R)
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 2 Feb 2011
Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Feb 2011
Amarin Corporation Appoints Industry Veteran Paul E. Huff as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Feb 2011
Genocea Biosciences Announces Promotion of Chip Clark to President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Feb 2011
Constellation Pharmaceuticals Expands Leadership Team with Drug Development Industry Veterans
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Feb 2011
FDA Issues Complete Response to New Drug Application for Contrave(R) for the Management of Obesity
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Feb 2011
Soligenix Appoints Kevin Horgan, MD, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Feb 2011
Omeros Announces Eligibility of OMS103HP for EMA Centralized Marketing Application
Biopharmaceuticals Orthopaedic Regulatory
 HSMN NewsFeed - 1 Feb 2011
Valeant Pharmaceuticals to Acquire PharmaSwiss S.A.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 31 Jan 2011
AVANIR Pharmaceuticals Announces U.S. Launch and Availability of NUEDEXTA for Pseudobulbar Affect
Biopharmaceuticals Neurology
 HSMN NewsFeed - 31 Jan 2011
Dr. Yvonne Greenstreet Joins Pfizer As Senior Vice President And Head Of Medicines Development, Specialty Care Business Unit
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jan 2011
Genzyme Will Allow sanofi-aventis to Conduct Due Diligence
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 31 Jan 2011
Cook Pharmica Adds E. Morrey Atkinson, Ph.D., to Leadership Team as Vice President of Research and Development, Chief Scientific Officer
Devices Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jan 2011
GATTEX(R) (teduglutide) Meets Primary Efficacy Endpoint in Phase 3 Pivotal Study in Patients with Adult Short Bowel Syndrome
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 28 Jan 2011
Mylan Receives Approval for First-to-File Generic Sular(R) Extended-Release Tablets
Biopharmaceuticals Cardiology Generics FDA
 HSMN NewsFeed - 27 Jan 2011
H3 Biomedicine Launches to Discover and Develop Next Generation Cancer Treatments
Biopharmaceuticals Personalized Medicine Oncology
 HSMN NewsFeed - 27 Jan 2011
CSL Behring Receives National Marketing Authorization of Berinert(R) in Israel
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Jan 2011
Swedish Orphan Biovitrum agrees with Fresenius Biotech to distribute Removab(R)
Biopharmaceuticals Oncology Distribution
 HSMN NewsFeed - 27 Jan 2011
REMOXY New Drug Application Accepted by FDA
Biopharmaceuticals Pain Management
 HSMN NewsFeed - 27 Jan 2011
Newly Published Data Demonstrates Caldolor(R) Significantly Reduces Pain and Morphine Use in Post-Operative Patients
Biopharmaceuticals Pain Management Surgery
 HSMN NewsFeed - 26 Jan 2011
Ligand Acquires CyDex Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Jan 2011
Teva to Acquire Corporación Infarmasa
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Jan 2011
APP Pharmaceuticals Announces Agreement with Teva Pharmaceuticals to Manufacture and Market Gemcitabine HCI for Injection
Biopharmaceuticals Licensing Oncology
Older Biopharmaceutical stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!